Two cases of primary malignant melanoma of the penis are described, bringing the total number of cases reported in the literature to 36. The clinico-pathological aspects of this lesion have been discussed and the literature has been reviewed. Both patients presented with lesions involving the glans penis. The duration of symptoms was 2 and 3 months, respectively. Both patients were treated by total amputation of the penis and by dissection of the inguinal lymph nodes. Metastatic deposits were present in the inguinal lymph nodes in both cases. One patient died 6 months after presentation with local recurrence and evidence of distant metastases, while the other is alive and well 13 months after leaving hospital. Malignant melanoma of the penis usually occurs between the age of 50 and 80 years. The duration of symptoms, as well as the behaviour of the lesion, are variable. The most common presenting symptom is the presence of a dark nodule on the glans, which is enlarging and ulcerating. Histologically the lesion shows typical appearances of pigmented malignant melanoma. Spread of the tumour occurs via the lymphatics to the inguinal lymph nodes, and often occurs early in the course of the disease. Haematogenous spread to distant organs tends to occur later. The recommended treatment is surgical, governed by the site and extent of the lesion. Patients who do not have metastases at the time of presentation appear to have better prognosis, although the behaviour of the lesion may be unpredictable. The prognosis on the whole is not good, but may be improved by earlier diagnosis and adequate treatment.

Keywords:
Malignant melanoma, Penis, Melanoma
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.